Subjective Well Being of Schizophrenic Patients in Greece (AURA)

AstraZeneca

Status: Completed

Conditions: Schizophrenia

Study type: Observational

Funder types: Industry

Identifiers

NCT00857064

NIS-NGR-DUM-2008/2

Details and patient eligibility

About

Non-interventional study aiming to provide data on the subjective effects of antipsychotic medication assessing subjective well-being and global functioning of patients with Schizophrenia under antipsychotic medication. Moreover it aims to assess their adherence to the treatment and will investigate whether there is any correlation of these factors with the clinical condition of these patients.

Enrollment: 600 patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Provision of written informed consent
• Diagnosis of schizophrenia according to DSM-IV
• The patient must have been prescribed an atypical antipsychotic for at least 4 weeks before the first study visit

Exclusion criteria